Published in Pediatr Transplant on October 01, 2004
Polyomaviruses KI and WU in immunocompromised patients with respiratory disease. Emerg Infect Dis (2009) 1.29
Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy. PLoS One (2011) 1.25
BK virus infection, replication, and diseases in pediatric kidney transplantation. Pediatr Nephrol (2007) 1.05
JC virus variant associated with cerebellar atrophy in a patient with AIDS. J Clin Microbiol (2011) 1.02
Monitoring of polyomavirus BK virus viruria and viremia in renal allograft recipients by use of a quantitative real-time PCR assay: one-year prospective study. J Clin Microbiol (2007) 0.96
Monitoring and managing viral infections in pediatric renal transplant recipients. Pediatr Nephrol (2011) 0.86
Internally controlled triplex quantitative PCR assay for human polyomaviruses JC and BK. J Clin Microbiol (2008) 0.86
The BK virus in renal transplant recipients-review of pathogenesis, diagnosis, and treatment. Pediatr Nephrol (2010) 0.81
Activities of different classes of acyclic nucleoside phosphonates against BK virus in primary human renal cells. Antimicrob Agents Chemother (2011) 0.77
BK virus-associated transplant nephropathy: need for increased awareness in children. Pediatr Transplant (2004) 0.75
Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med (2005) 6.33
Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol (2012) 4.26
Intrarenal resistive index after renal transplantation. N Engl J Med (2013) 4.19
Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol (2011) 3.87
Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J Virol (2008) 3.73
Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst (2004) 3.20
Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol (2008) 2.77
Similar compliance and effect of treatment in chronic hepatitis C resulting from intravenous drug use in comparison with other infection causes. Eur J Gastroenterol Hepatol (2006) 2.47
Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event. J Virol (2005) 2.35
A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium. BMC Infect Dis (2005) 2.28
Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol (2009) 2.21
Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivation. J Antimicrob Chemother (2005) 2.14
Evolutionary history and global spread of the emerging g12 human rotaviruses. J Virol (2006) 2.12
RotaC: a web-based tool for the complete genome classification of group A rotaviruses. BMC Microbiol (2009) 2.06
A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences. Nucleic Acids Res (2009) 2.06
Hantaviruses: immunology, treatment, and prevention. Viral Immunol (2004) 2.00
VP6-sequence-based cutoff values as a criterion for rotavirus species demarcation. Arch Virol (2012) 1.78
Influence of 2-substituent on the activity of imidazo[1,2-a] pyridine derivatives against human cytomegalovirus. Bioorg Med Chem (2002) 1.77
Ancient papillomavirus-host co-speciation in Felidae. Genome Biol (2007) 1.75
Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication. Cell Host Microbe (2011) 1.74
Prevalence of G2P[4] and G12P[6] rotavirus, Bangladesh. Emerg Infect Dis (2007) 1.73
Synthesis and antiviral activity of new pyrazole and thiazole derivatives. Eur J Med Chem (2009) 1.71
Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts. J Am Soc Nephrol (2009) 1.69
A sequence-independent strategy for detection and cloning of circular DNA virus genomes by using multiply primed rolling-circle amplification. J Virol (2004) 1.64
Are human P[14] rotavirus strains the result of interspecies transmissions from sheep or other ungulates that belong to the mammalian order Artiodactyla? J Virol (2009) 1.62
Full genomic analysis of human rotavirus strain B4106 and lapine rotavirus strain 30/96 provides evidence for interspecies transmission. J Virol (2006) 1.61
The histology of kidney transplant failure: a long-term follow-up study. Transplantation (2014) 1.61
Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G protein. J Virol (2005) 1.60
Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread. Mol Biol Evol (2010) 1.57
Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am J Transplant (2004) 1.54
Relating increasing hantavirus incidences to the changing climate: the mast connection. Int J Health Geogr (2009) 1.48
Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate. J Cell Mol Med (2009) 1.48
Molecular evolution and circulation patterns of human respiratory syncytial virus subgroup a: positively selected sites in the attachment g glycoprotein. J Virol (2004) 1.48
Search for polymorphisms in the genes for herpesvirus entry mediator, nectin-1, and nectin-2 in immune seronegative individuals. J Infect Dis (2001) 1.47
Animal papillomaviruses. Virology (2013) 1.47
Characterization of a novel P[25],G11 human group a rotavirus. J Clin Microbiol (2005) 1.46
G8 rotavirus strains isolated in the Democratic Republic of Congo belong to the DS-1-like genogroup. J Clin Microbiol (2006) 1.46
Evolutionary dynamics of human rotaviruses: balancing reassortment with preferred genome constellations. PLoS Pathog (2009) 1.43
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem Biophys Res Commun (2004) 1.42
Evolutionary history of the closely related group 2 coronaviruses: porcine hemagglutinating encephalomyelitis virus, bovine coronavirus, and human coronavirus OC43. J Virol (2006) 1.42
p53 Immunohistochemistry expression in Wilms tumor: a prognostic tool in the detection of tumor aggressiveness. J Urol (2012) 1.42
Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing. PLoS One (2012) 1.41
Synthesis and antiviral activity of 2,4-diamino-5-cyano-6-[2-(phosphonomethoxy)ethoxy]pyrimidine and related compounds. Bioorg Med Chem (2004) 1.41
Molecular typing and epidemiology of enteroviruses identified from an outbreak of aseptic meningitis in Belgium during the summer of 2000. J Med Virol (2003) 1.40
Subgroup prevalence and genotype circulation patterns of human respiratory syncytial virus in Belgium during ten successive epidemic seasons. J Clin Microbiol (2007) 1.39
Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq. J Clin Microbiol (2011) 1.33
Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study. Pediatr Nephrol (2009) 1.32
Genotype constellation and evolution of group A rotaviruses infecting humans. Curr Opin Virol (2012) 1.29
Peripheral bile duct paucity and cholestasis in the liver of a patient with Alagille syndrome: further evidence supporting a lack of postnatal bile duct branching and elongation. Am J Surg Pathol (2005) 1.29
Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine (2010) 1.28
5-Substituted-2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidines-acyclic nucleoside phosphonate analogues with antiviral activity. J Med Chem (2003) 1.28
Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0. J Clin Microbiol (2008) 1.27
Cattle pathogen tritrichomonas foetus (Riedmüller, 1928) and pig commensal Tritrichomonas suis (Gruby & Delafond, 1843) belong to the same species. J Eukaryot Microbiol (2002) 1.25
Analysis of the serotype and genotype correlation of VP1 and the 5' noncoding region in an epidemiological survey of the human enterovirus B species. J Clin Microbiol (2004) 1.22
High-level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt/PKB. J Pathol (2005) 1.22
Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology. J Magn Reson Imaging (2012) 1.22
Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure. Am J Hum Genet (2009) 1.21
Cidofovir resistance in vaccinia virus is linked to diminished virulence in mice. J Virol (2006) 1.21
Cloning and genomic characterization of Felis domesticus papillomavirus type 1. Virology (2002) 1.19
A proposal for new criteria for the classification of hantaviruses, based on S and M segment protein sequences. Infect Genet Evol (2009) 1.18
Drug targets in cytomegalovirus infection. Infect Disord Drug Targets (2009) 1.17
Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft cultures. Antivir Ther (2007) 1.17
Expression of complement components differs between kidney allografts from living and deceased donors. J Am Soc Nephrol (2009) 1.16
6-[2-(Phosphonomethoxy)alkoxy]pyrimidines with antiviral activity. J Med Chem (2002) 1.16
Isolation and cloning of the raccoon (Procyon lotor) papillomavirus type 1 by using degenerate papillomavirus-specific primers. J Gen Virol (2005) 1.16
Investigating the origin and spread of hepatitis C virus genotype 5a. J Virol (2006) 1.16
Novel inhibitors of human CMV. Curr Opin Investig Drugs (2008) 1.16
Cobalamin disorder Cbl-C presenting with late-onset thrombotic microangiopathy. Am J Med Genet (2002) 1.11
Chromatography paper strip sampling of enteric adenoviruses type 40 and 41 positive stool specimens. Virol J (2005) 1.11
A pancoronavirus RT-PCR assay for detection of all known coronaviruses. Methods Mol Biol (2008) 1.11
Avian papillomaviruses: the parrot Psittacus erithacus papillomavirus (PePV) genome has a unique organization of the early protein region and is phylogenetically related to the chaffinch papillomavirus. BMC Microbiol (2002) 1.11
Synthesis and biological evaluation of acyclic 3-[(2-hydroxyethoxy)methyl] analogues of antiviral furo- and pyrrolo[2,3-d]pyrimidine nucleosides. J Med Chem (2005) 1.10
Two out of the 11 genes of an unusual human G6P[6] rotavirus isolate are of bovine origin. J Gen Virol (2008) 1.10
A genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope gene. J Virol Methods (2005) 1.10
Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford) (2010) 1.10
Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant (2005) 1.09
Genomic characterization of novel dolphin papillomaviruses provides indications for recombination within the Papillomaviridae. Virology (2008) 1.08
Genomic characterization of a novel virus found in papillomatous lesions from a southern brown bandicoot (Isoodon obesulus) in Western Australia. Virology (2008) 1.05
The health and economic burden of rotavirus disease in Belgium. Eur J Pediatr (2008) 1.05
Herpes simplex virus drug-resistance: new mutations and insights. Curr Opin Infect Dis (2013) 1.04
Multiple reassortment and interspecies transmission events contribute to the diversity of feline, canine and feline/canine-like human group A rotavirus strains. Infect Genet Evol (2011) 1.03
Antiviral properties of new arylsulfone derivatives with activity against human betaherpesviruses. Antiviral Res (2006) 1.03
No response to first-line tenofovir+lamivudine+efavirenz despite optimization according to baseline resistance testing: impact of resistant minority variants on efficacy of low genetic barrier drugs. J Clin Virol (2007) 1.03
Recent approaches in hantavirus vaccine development. Expert Rev Vaccines (2009) 1.03
Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3. Cancer Res (2014) 1.02
Activities of alkoxyalkyl esters of cidofovir (CDV), cyclic CDV, and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against orthopoxviruses in cell monolayers and in organotypic cultures. Antimicrob Agents Chemother (2006) 1.02
Development of one-step, real-time, quantitative reverse transcriptase PCR assays for absolute quantitation of human coronaviruses OC43 and 229E. J Clin Microbiol (2005) 1.02
Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010). Vaccine (2010) 1.01
Practical and efficient synthesis of pyrano[3,2-c]pyridone, pyrano[4,3-b]pyran and their hybrids with nucleoside as potential antiviral and antileishmanial agents. Bioorg Med Chem Lett (2010) 1.01
Next-generation treatment strategies for human papillomavirus-related head and neck squamous cell carcinoma: where do we go? Rev Med Virol (2011) 1.00
Prognostic significance of Gremlin1 (GREM1) promoter CpG island hypermethylation in clear cell renal cell carcinoma. Am J Pathol (2009) 1.00
Comparison of the FilmArray RP, Verigene RV+, and Prodesse ProFLU+/FAST+ multiplex platforms for detection of influenza viruses in clinical samples from the 2011-2012 influenza season in Belgium. J Clin Microbiol (2013) 1.00